Correction: β-Lactam–Induced Encephalopathy: An Underrecognized Complication Of Commonly Used Antibiotics—A Case Report - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: β-Lactam-Associated Encephalopathy, an Overlooked Complication of Common Antibiotics: Case Report

  • By

  • Gabriel Bronz

  • Georgiana Ciobanu

  • Adam Ogna

  • Didar Utebay

  • October 27, 2026

Share

Clinical Report: Correction to β-Lactam-Associated Encephalopathy Case Report

Overview

The notice corrects the author-name order in the original case report, “β-Lactam-Associated Encephalopathy, an Overlooked Complication of Common Antibiotics.” The accurate names are Bronz Gabriel, Ciobanu Georgiana, Ogna Adam, and Utebay Didar; the original article has been corrected.

Background

The corrected article concerns β-lactam-associated encephalopathy, described in its title as an overlooked complication of commonly used antibiotics. The supplied correction does not provide clinical details about the case, diagnostic findings, treatment, or outcome. Related materials describe other antimicrobial-associated clinical concerns, including resistant infections and antibiotic dosing, but do not add details about this case report. This report therefore summarizes the correction rather than the underlying clinical case.

Data Highlights

This correction reports an author-name ordering error and its correction; it provides no numerical or trial data.

Key Findings

  • The correction applies to the article “β-Lactam-Associated Encephalopathy, an Overlooked Complication of Common Antibiotics: Case Report.”
  • The original article was published in Infection.
  • The author names had their given and family names arranged incorrectly.
  • The accurate author order is Bronz Gabriel, Ciobanu Georgiana, Ogna Adam, and Utebay Didar.
  • The source states that the original article has undergone correction.

Clinical Implications

The notice concerns author attribution and does not report a change to clinical findings or recommendations. No case-specific diagnostic or treatment guidance is provided in the supplied correction.

Conclusion

The correction establishes the accurate author-name order for the case report. The supplied notice contains no further clinical information about β-lactam-associated encephalopathy.

Related Resources & Content

  1. Bronz Gabriel, Ciobanu Georgiana, Ogna Adam, Utebay Didar, Infection, 2026 -- Correction: β-Lactam-Associated Encephalopathy, an Overlooked Complication of Common Antibiotics: Case Report
  2. Frontiers in Medicine — Severe pneumocephalus linked to a lethal central nervous system infection from NDM-1-producing carbapenem-resistant Klebsiella pneumoniae: a case study
  3. Infection — Infections from Extended-Spectrum Beta-Lactamase Producing Enterobacterales (ESBL-E) in Hospitalized Patients: A Comparative Cohort Analysis of 2971 Carriers and 2971 Non-Carriers
  4. International Journal of Infectious Diseases — Inappropriate Initial Therapy and Excessive Broad-Spectrum Antibiotic Use for Community-Onset Bloodstream Infections: A Retrospective Cohort Study
  5. mdspire news — Antibiotic precedes auto-brewery relapse
  6. Consensus Guidance for Beta‐Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti‐Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases Pharmacists
  7. Cefepime-Induced Neurotoxicity: When Should Alternative Agents Be Considered? | NEJM Clinician
  8. Agent-Specific Clinical Profiles of Antibiotic-Associated Encephalopathy: A Dual-Database Pharmacovigilance Study Using JADER and FAERS.

Original Source(s)

Related Content